Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.6M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
16.5M
-
Shares change
-
+368K
-
Total reported value, excl. options
-
$193M
-
Value change
-
+$734K
-
Put/Call ratio
-
2.88
-
Number of buys
-
42
-
Number of sells
-
-40
-
Price
-
$11.71
Significant Holders of Neurogene Inc. - Common Stock (NGNE) as of Q1 2025
107 filings reported holding NGNE - Neurogene Inc. - Common Stock as of Q1 2025.
Neurogene Inc. - Common Stock (NGNE) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.5M shares
.
Largest 10 shareholders include SAMSARA BIOCAPITAL, LLC (1.72M shares), BAKER BROS. ADVISORS LP (1.49M shares), BlackRock, Inc. (1.4M shares), RTW INVESTMENTS, LP (1.35M shares), Redmile Group, LLC (1.31M shares), Casdin Capital, LLC (1.3M shares), EcoR1 Capital, LLC (1.27M shares), COMMODORE CAPITAL LP (925K shares), VANGUARD GROUP INC (618K shares), and GREAT POINT PARTNERS LLC (471K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.